Antifungal drug target prioritization using Cryptococcus neoformans

使用新型隐球菌进行抗真菌药物靶点优先排序

基本信息

  • 批准号:
    8418700
  • 负责人:
  • 金额:
    $ 18.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-02-15 至 2015-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Fungal diseases in humans are extremely common. They include mild cosmetic symptoms, recurrent skin and mucosal surface infections, and the rarer life-threatening diseases caused by disseminated fungi particularly in immunocompromised patients such as those suffering from AIDS, undergoing chemotherapy or corticosteroid therapy, and organ transplant recipients. Currently there is a limited repertoire of drugs available to treat fungi. Some species are naturally resistance to these drugs and resistance can be acquired in clinical settings. Thus, there is an urgent need to develop new treatments for fungal diseases. The objective of this proposal is to identify suitable targets for drug development in fungi, using a model organism Cryptococcus neoformans (in phylum Basidiomycota). This fungus is very diverged and different from commonly studied pathogenic or model species like Candida albicans, Saccharomyces cerevisiae or Schizosaccharomyces pombe (in phylum Ascomycota), and thus discoveries made in this organism are expected to extend across all pathogenic fungi. The specific aim of the proposed research is to identify essential genes of C. neoformans, using two experimental approaches. Essential genes are those required for viability: because mutants cannot grow, the identification of essential genes is a technical challenge. Here these genes will be identified by an innovative genetic screen and through a bioinformatic prioritization to essential genes found in fungi but not in humans. The proposal will also generate a resource of heterozygous strains suitable for small molecule studies utilizing haplo-insufficiency. The discovery of these essential genes represents new avenues for the development of antifungal agents.
描述(由申请人提供):真菌疾病在人类中非常常见。它们包括轻微的美容症状,反复出现的皮肤和粘膜表面感染,以及由播散性真菌引起的罕见的危及生命的疾病,特别是在艾滋病患者、接受化疗或皮质类固醇治疗的患者和器官移植接受者中。目前,用于治疗真菌的药物有限。有些物种对这些药物具有天然耐药性,在临床环境中可获得耐药性。因此,迫切需要开发新的治疗真菌疾病的方法。本提案的目的是利用一种模式生物新隐球菌(担子菌门)来确定真菌药物开发的合适靶点。这种真菌非常分化,不同于通常研究的致病或模式物种,如白色念珠菌、酿酒酵母菌或pombe Schizosaccharomyces(子囊菌门),因此在这种生物中取得的发现有望扩展到所有致病真菌。该研究的具体目的是利用两种实验方法来鉴定新生芽孢杆菌的基本基因。必要基因是生存所需的基因:因为突变体不能生长,鉴定必要基因是一项技术挑战。在这里,这些基因将通过一种创新的基因筛选和生物信息学的优先顺序来识别,这些基因在真菌中发现,但在人类中没有。该建议还将产生适合利用单倍不足进行小分子研究的杂合菌株资源。这些重要基因的发现为开发抗真菌药物开辟了新的途径。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak.
  • DOI:
    10.1038/ncomms6194
  • 发表时间:
    2014-10-17
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Voelz, Kerstin;Johnston, Simon A.;Smith, Leanne M.;Hall, Rebecca A.;Idnurm, Alexander;May, Robin C.
  • 通讯作者:
    May, Robin C.
Exploring and exploiting the connection between mitochondria and the virulence of human pathogenic fungi.
  • DOI:
    10.1080/21505594.2017.1414133
  • 发表时间:
    2018-01-01
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Verma S;Shakya VPS;Idnurm A
  • 通讯作者:
    Idnurm A
Intracellular Ca(2+) and K(+) concentration in Brassica oleracea leaf induces differential expression of transporter and stress-related genes.
  • DOI:
    10.1186/s12864-016-2512-x
  • 发表时间:
    2016-03-09
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Lee J;Kim J;Choi JP;Lee M;Kim MK;Lee YH;Hur Y;Nou IS;Park SU;Min SR;Kim H
  • 通讯作者:
    Kim H
A silver bullet in a golden age of functional genomics: the impact of Agrobacterium-mediated transformation of fungi.
  • DOI:
    10.1186/s40694-017-0035-0
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Idnurm A;Bailey AM;Cairns TC;Elliott CE;Foster GD;Ianiri G;Jeon J
  • 通讯作者:
    Jeon J
The contribution of the White Collar complex to Cryptococcus neoformans virulence is independent of its light-sensing capabilities.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER IDNURM其他文献

ALEXANDER IDNURM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER IDNURM', 18)}}的其他基金

Antifungal drug target prioritization using Cryptococcus neoformans
使用新型隐球菌进行抗真菌药物靶点优先排序
  • 批准号:
    8242326
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Light-regulated genes affecting the pathogen potential of Cryptococcus neoformans
影响新型隐球菌致病潜力的光调控基因
  • 批准号:
    7495603
  • 财政年份:
    2007
  • 资助金额:
    $ 18.75万
  • 项目类别:
Light-regulated genes affecting the pathogen potential of Cryptococcus neoformans
影响新型隐球菌致病潜力的光调控基因
  • 批准号:
    7249522
  • 财政年份:
    2007
  • 资助金额:
    $ 18.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了